This narrative review explores the potential of proliferative markers, namely Ki‐67, PCNA, PHH3, and Cyclin D1, as predictive and prognostic tools in pancreatic cancer chemotherapy. The gene discussed is CCND1; the disease is familial pancreatic carcinoma.